NARINE JEENARINE

CIK 00014658221 companyLAURELTON, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001465822

Recent Transactions

50 trades

Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2016-04-13−2,424,333→ 0 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2016-04-13−1,242,334→ 2,935,986 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2016-04-13$0.06/sh+4,000,000→ 16,742,395 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2016-04-13−333,333→ 0 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2016-02-16$0.25/sh+81,549→ 12,742,395 total
Gift
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2015-12-31−6,000,000→ 12,262,006 total
Gift
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-12-31−6,000,000→ 3,910,532 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2015-10-30+398,840→ 398,840 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2015-04-23−67,659,232→ 0 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2015-04-23+12,850,089→ 31,269,108 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-04-03−2,454,665→ 0 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-04-03+9,910,532→ 9,910,532 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-04-03−4,000,000→ 0 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-04-03−6,726,999→ 0 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2015-04-03−40,000,000→ 0 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
common
2015-03-05$0.34/sh+58,475→ 5,568,930 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2014-10-17−20,000,002→ 6,726,999 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2014-10-17+4,178,320→ 8,602,653 total
Gift
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2014-08-08−2,000,000→ 2,757,666 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-04-02$0.41/sh+147,667→ 5,682,877 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-04-01$0.41/sh−157,012→ 5,830,544 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-03-27$0.43/sh−190,172→ 5,987,556 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-03-11$0.60/sh−239,367→ 14,887,229 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-03-07$0.68/sh−1,051,450→ 14,939,890 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-03-06$0.90/sh−773,050→ 15,171,209 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-02-25$0.09/sh+220,106→ 6,177,728 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2014-01-13$0.18/sh−805,583→ 15,341,280 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-12-05$0.13/sh−275,000→ 15,621,069 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-12-02$0.13/sh−100,000→ 15,686,768 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-27$0.12/sh−25,000→ 15,708,769 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-26$0.12/sh−23,626→ 15,681,569 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-26$0.12/sh−357,000→ 15,714,268 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-19$0.12/sh−21,000→ 15,801,388 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-18$0.12/sh−1,170,000→ 15,806,008 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-15$0.12/sh−318,050→ 16,063,408 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-15$0.12/sh−253,050→ 16,049,109 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-14$0.12/sh−465,090→ 16,133,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-11$0.12/sh−39,000→ 15,792,808 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-11-06$0.12/sh−122,200→ 16,235,699 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-10-29$0.01/sh−102,520→ 16,262,583 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-10-28$0.13/sh−102,300→ 16,365,103 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-09-10$0.02/sh+14,485,597→ 16,467,403 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Confertible Preferred Stock
2013-09-10−1,600→ 0 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-05-09$0.07/sh−391,500→ 14,965,834 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.04/sh−13,367,481→ 15,357,334 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.08/sh−130,000→ 24,268,988 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.08/sh−140,000→ 24,268,978 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2013-04-26+4,424,333→ 26,727,001 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-26$0.04/sh+4,455,827→ 9,399,712 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-26$0.08/sh−243,926→ 16,168,535 total

Companies

ELITE PHARMACEUTICALS INC /NV/
Director, 10% Owner
$ELTP

Recent Filings

Address

C/O EPIC PHARMA, LLC 227-15 NORTH CONDUIT AVENUE

LAURELTON, NY, 11413-3134

View on SEC.gov